Cinnamon Rolls (Pillsbury) – Foreign Object Risk (2013)
Class II: A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Class II recall indicates potential for temporary health effects.
This AI-generated summary is provided for general informational purposes only and is derived from publicly available recall notices. It supplements but does not replace official agency classifications or safety instructions.
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
Pills bury Cinnamon Rolls with Icing, CINNA BON, USPC 1800000501, 1800052230, 12.4 oz and 2-pack USPC 1800045675,2- 12.4 oz (351 G) CANS, NET WT 24.8 OZ (1 LB 8.8 OZ 703 G.
Brand
General Mills, Inc
Lot Codes / Batch Numbers
Better if Used Date on Package: 30OCT2013, 31OCT2013, 18OCT2013, 26OCT2013 and 31OCT2013.
Products Sold
Better if Used Date on Package: 30OCT2013, 31OCT2013, 18OCT2013, 26OCT2013 and 31OCT2013.
General Mills, Inc is recalling Pills bury Cinnamon Rolls with Icing, CINNA BON, USPC 1800000501, 1800052230, 12.4 oz and 2-pack US due to General Mills is recalling a limited quantity of refrigerated Pills bury Cinnamon Rolls with Icing. The dough may contain fragments from a broken pie. This is a Class I recall, indicating a high risk of serious health consequences. Based on FDA enforcement report.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
General Mills is recalling a limited quantity of refrigerated Pills bury Cinnamon Rolls with Icing. The dough may contain fragments from a broken piece of plastic on the production line.
Recommended Action
Per FDA guidance
Consumers should stop using the product and contact the recalling firm or return it to the place of purchase.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticeDistribution
As reported by FDA
AL, AZ, AR, CA, CO, CT, FL, GA, ID, IL, IN, KS, KY, LA, ME, MD, MA, MI, MN, MS, MO, MT, NE, NV, NH, NJ, NM, NY, NC, ND, OH, OK, OR, PA, SC, SD, TN, TX, UT, VA, WA, WI, WY
Page updated: Jan 6, 2026